• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY XD; CORONARY DRUG-ELUTING STENT Back to Search Results
Lot Number 0030807929
Device Problem Contamination (1120)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/20/2023
Event Type  malfunction  
Event Description
It was reported that the device was contaminated.A 4.00 x 20mm synergy xd drug-eluting stent was selected for use.After implanting the device, a yellow substance was noted inside the packaging of the bag.The device remains inside the patient.There were no patient injuries reported.
 
Manufacturer Narrative
Device evaluated by mfr: received for analysis was the dual chamber pouch (dcp) / inner pouch, from this synergy xd mr ous 4.00 x 20mm.An examination of the pouch noted that the pouch had been opened however, an examination of the inside of the inner pouch identified a yellow residue stretching across the pouch.The yellow residue was scanned and it was found to be a condensate from molten polymer vapors collected from exhaust ductwork over a film extruder, at the site of the external vendor manufacturing site.The amber colored oily substance (yellow substance trapped in the pouch) is consistent with the appearance of condensate, which the vendor manufacturer had identified in the past.The dual chamber pouch is composed of 7 layers.The residue is encapsulated between the foil and nylon layer - a puncture resistant layer, preventing a barrier to movement of the residue towards the seal layer and the product chamber.Therefore, the residue did not come in contact with the inner facing layer of the pouch which would be in contact with the actual device.
 
Event Description
It was reported that the device was contaminated.A 4.00 x 20mm synergy xd drug-eluting stent was selected for use.After implanting the device, a yellow substance was noted inside the packaging.The device remains inside the patient.There were no patient injuries reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY XD
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18107765
MDR Text Key329200151
Report Number2124215-2023-61220
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Lot Number0030807929
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/08/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-